ArteraAI Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
136
- Latest Deal Type
-
Mezzanine
- Latest Deal Amount
-
$11.3M
- Investors
-
33
ArteraAI General Information
Description
Developer of AI-enabled predictive and prognostic cancer tests designed to identify patients who will benefit from therapy intensification. The company's tests leverage an algorithm that assesses digital images from a patient's biopsy and learns from a patient's clinical data, enabling clinicians with more information to make informed treatment decisions.
Contact Information
Website
www.artera.aiCorporate Office
- 108 1st Street
- Los Altos, CA 94022
- United States
Corporate Office
- 108 1st Street
- Los Altos, CA 94022
- United States
ArteraAI Timeline
ArteraAI Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Mezzanine | 13-Mar-2026 | $11.3M | Completed | Generating Revenue | ||
| 3. Early Stage VC | 01-Aug-2025 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 01-Feb-2024 | $20M | $109M | Completed | Generating Revenue | |
| 1. Seed Round | 21-Mar-2023 | $89.5M | $89.5M | Completed | Generating Revenue |
ArteraAI Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-3 | ||||||||
| Seed-2 | ||||||||
| Seed-1 | 7,168,458 | $0.000010 | $0.03 | $0.03 | 1x | $0.03 | 14.25% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
ArteraAI Comparisons
Industry
Financing
Details
ArteraAI Competitors (26)
One of ArteraAI’s 26 competitors is CureMetrix, a Venture Capital-Backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CureMetrix | Venture Capital-Backed | San Diego, CA | ||||
| HealthMyne | Formerly VC-backed | Madison, WI | ||||
| InsightRx | Venture Capital-Backed | San Francisco, CA | ||||
| Decipher Urologic Cancers | Formerly VC-backed | San Diego, CA | ||||
| PreciseDx | Venture Capital-Backed | New York, NY |
ArteraAI Signals
ArteraAI Investors (33)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Eagle Point Trinity Senior Secured Lending Company BDC | Mezzanine | Minority | ||
| Trinity Capital Inc BDC | Business Development Company | Minority | ||
| EnvisionX Capital | Venture Capital | Minority | ||
| SCB 10X | Corporate Venture Capital | Minority | ||
| Angel (individual) | Minority |
ArteraAI FAQs
-
When was ArteraAI founded?
ArteraAI was founded in 2021.
-
Where is ArteraAI headquartered?
ArteraAI is headquartered in Los Altos, CA.
-
What is the size of ArteraAI?
ArteraAI has 136 total employees.
-
What industry is ArteraAI in?
ArteraAI’s primary industry is Decision/Risk Analysis.
-
Is ArteraAI a private or public company?
ArteraAI is a Private company.
-
What is ArteraAI’s current revenue?
The current revenue for ArteraAI is .
-
How much funding has ArteraAI raised over time?
ArteraAI has raised $121M.
-
Who are ArteraAI’s investors?
Eagle Point Trinity Senior Secured Lending Company BDC, Trinity Capital Inc BDC, EnvisionX Capital, SCB 10X, and are 5 of 33 investors who have invested in ArteraAI.
-
Who are ArteraAI’s competitors?
CureMetrix, HealthMyne, InsightRx, Decipher Urologic Cancers, and PreciseDx are some of the 26 competitors of ArteraAI.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process